FDA Inspection
American Red Cross Blood SvcsAmerican Red Cross Blood Svcs – FDA Inspection, May 18, 2026
Record Details
This FDA Inspection record concerns American Red Cross Blood Svcs, with an inspection on May 18, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 6d375e7c-fdd2-4601-83a0-93c2dac7f01b
Inspection Facts
- Inspection number
- 1318204
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.65Safe, sanitary, orderly storage
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross Blood Svcs
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 20, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Svcs
- FDA Inspection 1119033 - 2020-02-27
- FDA Inspection 1024233 - 2017-08-30
- FDA Inspection 950839 - 2015-12-04
- FDA Inspection 836874 - 2013-06-12
- FDA Inspection 730996 - 2011-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.